This is not a bad result though I would appreciate others...

This is not a bad result though I would appreciate others opinions as well. Slow and steady gains in sales and income quarter after quarter. Momentum is building.

It is hard to judge what next quarter will bring in the way of sales. I suppose it depends on a few different variables, including when revenue from sales is actually received from distributors ie which quarter .The US has only just come in, we know from the past that it took 6 months for UK to add revenue. Distributors are definately growing, and so one might expect a similar increase in sales.

With a market cap of $15 million and current sales 1-2 million and growing fast quarter by quarter,how long will it be before some big pharma likes the look of it. These marketing wizzards could do wonders with the product. Time will tell I suppose.

Am interested in your thoughts Elite.

I think MJ did no favours for the share price by announcing the strong start to the quarter months back. The market was clearly expecting more and it did nothing for the share price back then either.

It seems like MJ could find $5 on the pavement and announce it as market sensative.

No offence MJ if your are reading ,I am a fan,keep up the good work.